Lorna M. Williamson

4.9k citations

72 papers · 3.3k indexed · h-index 29

Hematology top 0.5%
Biochemistry top 0.2%
Management of Technology and Innovation top 0.5%
Genetics top 2%
Critical Care and Intensive Care Medicine top 0.5%

Co-authors: Willem H. Ouwehand Dana V. Devine Rebecca Cardigan Mike Clark Kathryn L. Armour Hilary Jones Hannah Cohen Elizabeth M. Love
Topics: Blood groups and transfusion (37 papers)Blood transfusion and management (32 papers)Blood donation and transfusion practices (29 papers)
Cited by: Biochemistry Hematology Management of Technology and Innovation
Journals: The Lancet Journal of Clinical Investigation Blood
Partner nations: United Kingdom Netherlands Nigeria

In The Last Decade

Lorna M. Williamson

72 papers receiving 3.2k citations

Peers

Countries citing papers authored by Lorna M. Williamson

Since Specialization

Citations

This map shows the geographic impact of Lorna M. Williamson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorna M. Williamson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorna M. Williamson more than expected).

Fields of papers citing papers by Lorna M. Williamson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorna M. Williamson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorna M. Williamson. The network helps show where Lorna M. Williamson may publish in the future.

Co-authorship network of co-authors of Lorna M. Williamson

This figure shows the co-authorship network connecting the top 25 collaborators of Lorna M. Williamson. A scholar is included among the top collaborators of Lorna M. Williamson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorna M. Williamson. Lorna M. Williamson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reduced FcRn-mediated transcytosis of IgG2 due to a missing Glycine in its lower hinge 2019 ·Scientific Reports ·Nigel M. Stapleton,Maximilian Brinkhaus,Kathryn L. Armour,Arthur E. H. Bentlage,Steven W. de Taeye,(unknown),Juk Yee Mok,Giso Brasser,(unknown),Wim J.E. van Esch,Mike Clark,Lorna M. Williamson,C. Ellen van der Schoot,Gestur Vidarsson	26
2	Human IgG lacking effector functions demonstrate lower FcRn-binding and reduced transplacental transport 2018 ·Molecular Immunology ·Nigel M. Stapleton,Sylvia Armstrong‐Fisher,Jan Terje Andersen,C. Ellen van der Schoot,(unknown),Karen Page,(unknown),Masja de Haas,Lorna M. Williamson,Mike Clark,Gestur Vidarsson,Kathryn L. Armour	16
3	A randomized noninferiority crossover trial of corrected count increments and bleeding in thrombocytopenic hematology patients receiving 2‐ to 5‐ versus 6‐ or 7‐day–stored platelets 2015 ·Transfusion ·Sheila MacLennan,(unknown),Charlotte Llewelyn,Louise Choo,(unknown),Edwin Massey,Simon Stanworth,K. Pendry,Lorna M. Williamson	28
4	Clearance of Human IgG1-Sensitised Red Blood Cells In Vivo in Humans Relates to the In Vitro Properties of Antibodies from Alternative Cell Lines 2014 ·PLoS ONE ·Kathryn L. Armour,(unknown),(unknown),Cara J. Ellison,Christopher M. Kirton,(unknown),Lorna M. Williamson,Mike Clark	1
5	Challenges in the management of the blood supply 2013 ·The Lancet ·Lorna M. Williamson,Dana V. Devine	176
6	Neonatal transfusion 2013 ·Early Human Development ·Anne M. Kelly,Lorna M. Williamson	18
7	Pathogen inactivation of platelets using ultraviolet C light: effect on in vitro function and recovery and survival of platelets 2012 ·Transfusion ·(unknown),(unknown),Michael Wiltshire,(unknown),Luke Sonoda,Stephen Thomas,Axel Seltsam,Frank Tolksdorf,Lorna M. Williamson,Rebecca Cardigan	40
8	Preoperative blood transfusions for sickle cell disease 2012 ·Cochrane Database of Systematic Reviews ·Ceri Hirst,Lorna M. Williamson	20
9	Practices associated with ABO‐incompatible platelet transfusions: a BEST Collaborative international survey 2010 ·Transfusion ·Miquel Lozano,Nancy M. Heddle,Lorna M. Williamson,Grace Wang,James P. AuBuchon,Larry J. Dumont,(unknown)	32
10	Developing recombinant HPA-1a–specific antibodies with abrogated Fcγ receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia 2008 ·Journal of Clinical Investigation ·Cédric Ghevaert,David A. Wilcox,Juan Fang,Kathryn L. Armour,Mike Clark,Willem H. Ouwehand,Lorna M. Williamson	27
11	The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion‐associated graft‐versus‐host disease 2007 ·Transfusion ·Lorna M. Williamson,D. Stainsby,Hilary Jones,Elizabeth M. Love,C. Chapman,Cristina Navarrete,Geoff Lucas,(unknown),Angela Casbard,Hannah Cohen,(unknown)	71
12	Tracking and characterisation of transfused platelets by two colour, whole blood flow cytometry 2005 ·British Journal of Haematology ·D.L. Hughes,Gillian Evans,Paul Metcalfe,Alison H. Goodall,Lorna M. Williamson	14
13	Variables determining blockage of WBC‐depleting filters by Hb sickle cell trait donations 2004 ·Transfusion ·(unknown),Rebecca Cardigan,Jerard Seghatchian,Pranee Krailadsiri,Lorna M. Williamson	12
14	Differential binding to human FcγRIIa and FcγRIIb receptors by human IgG wildtype and mutant antibodies 2003 ·Molecular Immunology ·Kathryn L. Armour,Jan G. J. van de Winkel,Lorna M. Williamson,Mike Clark	59
15	The effect of methylene blue photoinactivation and methylene blue removal on the quality of fresh‐frozen plasma 2003 ·Transfusion ·(unknown),Rebecca Cardigan,O. Drummond,V. Hornsey,(unknown),David A. Young,Lorna M. Williamson,C. V. Prowse	48
16	Residual subset population analysis in WBC‐reduced blood components using real‐time PCR quantitation of specific mRNA 2001 ·Transfusion ·(unknown),Stephen F. Garner,Janet Sutherland,Lorna M. Williamson	25
17	The Serious Hazards of Transfusion (SHOT) Initiative: The UK Approach to Haemovigilance 2000 ·Vox Sanguinis ·Lorna M. Williamson,Hannah Cohen,Elizabeth M. Love,Hilary Jones,Audrey Todd,Kate Soldan	48
18	Evidence that anti‐HBc but not HBV DNA testing may prevent some HBV transmission by transfusion 1999 ·British Journal of Haematology ·Jean‐Pierre Allain,Patricia E. Hewitt,Richard S. Tedder,Lorna M. Williamson,(unknown)	98
19	Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods 1997 ·British Journal of Haematology ·Paul Metcalfe,Lorna M. Williamson,Chris Reutelingsperger,(unknown),Willem H. Ouwehand,Alison H. Goodall	146
20	Blood usage for elective surgery. A reappraisal of the need for autologous transfusion 1989 ·Clinical & Laboratory Haematology ·Lorna M. Williamson,M. Greaves	2

About Lorna M. Williamson

Lorna M. Williamson is a scholar working on Biochemistry, Management of Technology and Innovation and Hematology, having authored 72 papers that have together received 3.3k indexed citations. Recurring topics across this work include Blood groups and transfusion (37 papers), Blood transfusion and management (32 papers) and Blood donation and transfusion practices (29 papers). The work is most often cited by research in Biochemistry (1.2k citations), Hematology (1.7k citations) and Management of Technology and Innovation (685 citations). Lorna M. Williamson has collaborated with scholars based in United Kingdom, Netherlands and Nigeria. Frequent co-authors include Willem H. Ouwehand, Dana V. Devine, Rebecca Cardigan, Mike Clark, Kathryn L. Armour, Hilary Jones, Hannah Cohen, Elizabeth M. Love, C. Chapman and D. Stainsby. Their work appears in journals such as The Lancet, Journal of Clinical Investigation and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact